PL1845945T3 - Wytwarzanie postaci dawkowania ze stałą dyspersją mikrokrystalicznego związku aktywnego - Google Patents
Wytwarzanie postaci dawkowania ze stałą dyspersją mikrokrystalicznego związku aktywnegoInfo
- Publication number
- PL1845945T3 PL1845945T3 PL06706797T PL06706797T PL1845945T3 PL 1845945 T3 PL1845945 T3 PL 1845945T3 PL 06706797 T PL06706797 T PL 06706797T PL 06706797 T PL06706797 T PL 06706797T PL 1845945 T3 PL1845945 T3 PL 1845945T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- active agent
- dosage forms
- solid dispersion
- microcrystalline active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05002955A EP1690528A1 (de) | 2005-02-11 | 2005-02-11 | Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs |
| PCT/EP2006/001164 WO2006084696A1 (de) | 2005-02-11 | 2006-02-09 | Herstellung von dosierungsformen mit einer festen dispersion eines mikrokristallinen wirkstoffs |
| EP06706797.5A EP1845945B1 (de) | 2005-02-11 | 2006-02-09 | Herstellung von dosierungsformen mit einer festen dispersion eines mikrokristallinen wirkstoffs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1845945T3 true PL1845945T3 (pl) | 2018-05-30 |
Family
ID=34933712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06706797T PL1845945T3 (pl) | 2005-02-11 | 2006-02-09 | Wytwarzanie postaci dawkowania ze stałą dyspersją mikrokrystalicznego związku aktywnego |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10653625B2 (pl) |
| EP (2) | EP1690528A1 (pl) |
| JP (1) | JP5441339B2 (pl) |
| CA (1) | CA2597549C (pl) |
| DK (1) | DK1845945T3 (pl) |
| PL (1) | PL1845945T3 (pl) |
| WO (1) | WO2006084696A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101702878B (zh) * | 2007-05-11 | 2012-11-28 | 弗·哈夫曼-拉罗切有限公司 | 可溶性差的药物的药物组合物 |
| EP2356976A3 (en) * | 2008-03-07 | 2013-03-06 | Eveready Battery Company, Inc. | Shaving aid material |
| EP2140861A1 (en) * | 2008-06-30 | 2010-01-06 | Abbott GmbH & Co. KG | Pharmaceutical dosage form comprising polymeric carrier composition |
| ES2685472T3 (es) * | 2008-12-05 | 2018-10-09 | Bayer Intellectual Property Gmbh | Extrudidos con sustancias activas con forma de agujas |
| EP2359812A1 (en) * | 2010-01-18 | 2011-08-24 | Cephalon France | Oral lyophilised compositions |
| EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
| MX2013008476A (es) * | 2011-02-17 | 2013-08-12 | Hoffmann La Roche | Proceso para cristalizacion controlada de un ingrediente farmaceutico activo a partir del estado liquido superenfriado por extrusion de fusion en caliente. |
| EP2822539B1 (en) * | 2012-03-07 | 2018-11-21 | National Institute Of Pharmaceutical Education And Research (NIPER) | Nanocrystalline solid dispersion compositions |
| JP6867035B2 (ja) * | 2015-12-10 | 2021-04-28 | 国立大学法人千葉大学 | 結晶質薬物ナノ粒子の製造方法 |
| WO2017189995A1 (en) * | 2016-04-28 | 2017-11-02 | Amplipharm Pharmaceuticals, LLC | Temozolomide powder formulation |
| US9949967B2 (en) | 2016-04-28 | 2018-04-24 | Amplipharm Pharmaceuticals, LLC | Temozolomide powder formulation |
| US10285987B2 (en) | 2017-04-28 | 2019-05-14 | Amplipharm Pharmaceuticals, LLC | Device and kit for dosing and dispensing non-liquid medicine |
| CN110621305A (zh) | 2017-07-24 | 2019-12-27 | 爱科思华制药研发有限责任公司 | 高载药量药物组合物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE42901T1 (de) | 1984-03-05 | 1989-05-15 | Nitto Denko Corp | Haftendes arzneimittelpraeparat fuer perkutane absorption. |
| NL194389C (nl) | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
| JPS6110507A (ja) * | 1984-06-14 | 1986-01-18 | サンド・アクチエンゲゼルシヤフト | 新規遅効性製剤 |
| CH670201A5 (en) * | 1985-06-03 | 1989-05-31 | Sandoz Ag | Solid dispersions of water-insol. drugs - comprising coherent crystals of drug in water-soluble matrix |
| CA2016887A1 (en) * | 1989-05-16 | 1990-11-16 | Henrich H. Paradies | Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl propionic acids |
| WO1992018106A1 (en) * | 1991-04-16 | 1992-10-29 | Nippon Shinyaku Co., Ltd. | Method of manufacturing solid dispersion |
| ZA932268B (en) | 1992-03-30 | 1993-11-11 | Alza Corp | Polymer system containing a partially soluble compound |
| NZ270439A (en) * | 1995-02-02 | 1996-04-26 | Bernard Charles Sherman | Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer |
| CA2214895C (en) * | 1997-09-19 | 1999-04-20 | Bernard Charles Sherman | Improved pharmaceutical composition comprising fenofibrate |
| CN1190187C (zh) * | 1997-10-27 | 2005-02-23 | 默克专利股份有限公司 | 差水溶性药物的固态溶液和分散液 |
| CA2330472C (en) * | 1998-04-27 | 2007-09-04 | The Dow Chemical Company | Encapsulated active materials |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| BR0211028A (pt) * | 2001-06-22 | 2004-06-15 | Pfizer Prod Inc | Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto |
| JP2004267041A (ja) * | 2003-03-06 | 2004-09-30 | Sanei Gen Ffi Inc | 微細化固形物分散製剤およびその製造方法 |
| US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
-
2005
- 2005-02-11 EP EP05002955A patent/EP1690528A1/de not_active Withdrawn
-
2006
- 2006-02-09 US US11/884,164 patent/US10653625B2/en active Active
- 2006-02-09 CA CA2597549A patent/CA2597549C/en active Active
- 2006-02-09 PL PL06706797T patent/PL1845945T3/pl unknown
- 2006-02-09 EP EP06706797.5A patent/EP1845945B1/de active Active
- 2006-02-09 JP JP2007554502A patent/JP5441339B2/ja active Active
- 2006-02-09 DK DK06706797.5T patent/DK1845945T3/en active
- 2006-02-09 WO PCT/EP2006/001164 patent/WO2006084696A1/de active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| CA2597549A1 (en) | 2006-08-17 |
| EP1845945A1 (de) | 2007-10-24 |
| EP1690528A1 (de) | 2006-08-16 |
| CA2597549C (en) | 2015-01-20 |
| US20090012184A1 (en) | 2009-01-08 |
| WO2006084696A9 (de) | 2007-10-25 |
| EP1845945B1 (de) | 2017-11-22 |
| JP5441339B2 (ja) | 2014-03-12 |
| DK1845945T3 (en) | 2018-02-26 |
| JP2008543724A (ja) | 2008-12-04 |
| US10653625B2 (en) | 2020-05-19 |
| WO2006084696A1 (de) | 2006-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1845945T3 (pl) | Wytwarzanie postaci dawkowania ze stałą dyspersją mikrokrystalicznego związku aktywnego | |
| PL1743882T3 (pl) | Sposób do produkcji izocyjanianów | |
| IL188330A0 (en) | Processes for the preparation of | |
| IL185390A (en) | A solid dosage form | |
| IL194522A0 (en) | Process for the preparation of prasugrel | |
| IL196234A0 (en) | A process for the preparation of optically active cyclopropylamines | |
| PT1748990E (pt) | Processo para a preparação de telmisartan | |
| PL1856038T3 (pl) | Sposób wytwarzania zawierającego mocznik strumienia wodnego | |
| EP1937223A4 (en) | PELLET FORMULATION OF AN ALPHA1 RECEPTOR ANTAGONIST WITH DELAYED RELEASE AND METHOD OF MANUFACTURING THEREOF | |
| IL184562A (en) | Polymorph ivandront a, a process for its preparation and pharmaceutical preparations containing it | |
| IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
| ZA200804264B (en) | Process for the preparation of ferri-succinylcasein | |
| ZA200709788B (en) | Cannabinold active pharmaceutical ingredient for Improved dosage forms | |
| EP1976490A4 (en) | EXTENDED RELEASE TABLET CONTAINING ZALTOPROFEN AND PROCESS FOR PREPARING SAID TABLET | |
| PL1795186T5 (pl) | Preparat leku zawierający flupirtynę o kontrolowanym uwalnianiu substancji czynnej | |
| ZA200703495B (en) | Process for the preparation of irbesartan hydrochloride | |
| EP1939170A4 (en) | PROCESS FOR PREPARING GABAPENTINE HYDROCHLORIDE | |
| GB0402492D0 (en) | Pharmaceutically active compounds | |
| ZA200601910B (en) | Process for the preparation of organosilances | |
| IL186220A0 (en) | Processes for the preparation of atomoxetine hydrochloride | |
| IL213474A0 (en) | Processes for the preparation of cyclopropyl-amide derivatives | |
| IL184193A0 (en) | Processes for the preparation of aminoethoxybenzyl alcohols | |
| EP2083003A4 (en) | PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTACHLOROBUTANE | |
| PL1700855T3 (pl) | Sposób wytwarzania tazarotenu | |
| IL195062A0 (en) | Process for the preparation of solid sterile active pharmaceutical ingredient |